Research Article
Association between Recipient IL-15 Genetic Variant and the Prognosis of HBV-Related Hepatocellular Carcinoma after Liver Transplantation
Table 1
Demographic data for recurrence and nonrecurrence groups.
| | Recurrence group () | Nonrecurrence group () | value |
| | Recipient age (yr) | 48.47 ± 7.95 | 50.93 ± 8.82 | 0.152 | | Recipient male/female () | 35 (92.1)/3 (7.9) | 67 (90.5)/7 (9.5) | 0.783 | | Cirrhosis yes/no () | 30 (78.9)/8 (21.1) | 65 (87.8)/9 (12.2) | 0.214 | | Histologic grade () | | | 0.203 | | Differentiated | 28 (73.7) | 62 (83.8) | | | Undifferentiated | 10 (26.3) | 12 (16.2) | | Tumor size () | | | <0.001 | | <5 cm | 16 (42.1) | 57 (77.0) | | | ≥5 cm | 22 (57.9) | 17 (23.0) | | Multinodular yes/no () | 19 (50.0)/19 (50.0) | 28 (37.8)/46 (62.2) | 0.217 | | Tumor thrombus () | | | <0.001 | | Yes | 24 (63.2) | 19 (25.7) | | | No | 14 (37.8) | 55 (74.3) | | Serum AFP level at LT () | | | 0.489 | | <400 cm | 27 (71.1) | 57 (77.0) | | | ≥400 cm | 11 (28.9) | 17 (23.0) | | Tumor stage () | | | 0.003 | | I-II | 22 (57.9) | 62 (83.8) | | | III | 16 (42.1) | 12 (16.2) | | UCSF criteria in/out () | 18 (47.7)/20 (52.3) | 57 (77.0)/17 (23.0) | 0.002 |
|
|
